AzTrials
AzTrials

Sexual HarassmentREVISENCT06839937

A Virtual Reality Couples' Intervention for Sexual Victimization Prevention: a Gender-swapping Transformative Approach

A study testing REVISE - Virtual Reality Gender-Swap with Harassment Exposure and REVISE - Virtual Reality Gender-Swap without Harassment in people with Sexual Harassment and Gender Based Violence, run by Universitat Oberta de Catalunya.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to evaluate the effectiveness of REVISE (REalidad Virtual Inmersiva y SExualidad), an immersive virtual reality (IVR) intervention designed to promote empathy and reduce sexual harassment behaviors in heterosexual cisgender men. Read more about this study

Who is it for?
Ages 18 to 39 yearsHealthy volunteers can take part
Conditions the study is for
Sexual Harassment, Gender Based Violence, Empathy
What is being tested?
REVISE - Virtual Reality Gender-Swap with Harassment Exposure and REVISE - Virtual Reality Gender-Swap without Harassment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
No sites listed yet
Study dates
30 Mar 2027to 30 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 39 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Participants must be between 18 and 39 years old.
  • Couples must have been in a romantic relationship for at least six months.
  • Both partners must provide explicit informed consent to participate.
  • Participants must be able to read and write in Spanish to ensure comprehension of the study materials.

Who cannot join

  • Individuals with any physical condition that may hinder the use of VR equipment (e.g., epilepsy or severe motion sickness).
  • Individuals with a history of sexual harassment or problematic substance use, including drug or alcohol abuse.
  • Individuals experiencing significant mental health difficulties that require intensive treatment.
  • Participants with prior exposure to similar VR-based gender perspective-taking interventions.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Adrián Montesano, Doctor contact

+34625624172

amontesano@uoc.edu

Pablo Vallejo Medina, Doctor contact

+34613028333

pvallejom@uoc.edu

About this study

Official title: A Virtual Reality Couples' Intervention for Sexual Victimization Prevention: a Gender-swapping Transformative Approach (REVISE)

The goal of this clinical trial is to evaluate the effectiveness of REVISE (REalidad Virtual Inmersiva y SExualidad), an immersive virtual reality (IVR) intervention designed to promote empathy and reduce sexual harassment behaviors in heterosexual cisgender men.

The main questions that this study aims to answer are as follows.

Read more

Does experiencing gender swapping in IVR increase empathy towards survivors of sexual harassment?

Does the intervention modify attitudes toward gender roles and sexual harassment?

Researchers will compare the three experimental groups to evaluate the effects of IVR:

  1. Identity Exchange Group with Exposure to Sexual Harassment: Participants embodied their partner's identity in a VR harassment scenario.
  2. Identity Exchange Group without Harassment Exposure: Participants embodied their partner's identity in a neutral VR scenario.
  3. Third-person Observer Group: Participants observe a harassment scenario in VR from their own perspective.

Participants will:

  1. Attend one virtual reality session in a laboratory setting.
  2. Undergo pre- and post-intervention assessments and a three-month follow-up.
  3. Complete self-report questionnaires and physiological measures (eye tracking and pupillometry).
  4. Participate in semi-structured interviews about their experiences. This study aims to explore how immersive VR embodiment can be used as a tool for gender violence prevention by fostering perspective-taking and behavioral change.
Read the detailed description

This study is a randomized controlled trial (RCT) designed to evaluate the efficacy of REVISE (REalidad Virtual Inmersiva y SExualidad), an immersive virtual reality (IVR) intervention, to promote empathy and reduce sexual harassment behaviors in heterosexual cisgender men. This study will assess whether experiencing sexual harassment from a first-person perspective using IVR embodiment techniques can lead to changes in attitudes and behaviors related to gender roles and sexual violence.

Study Design

  • Design: Randomized controlled trial (RCT) with a 1:1:1 allocation ratio.
  • Population: 90 heterosexual cisgender couples (180 participants) aged 18-39 years.
  • Study Setting: This study will be conducted in a controlled laboratory environment at the Interdisciplinary Research and Innovation Hub of the Universitat Oberta de Catalunya (UOC), equipped with advanced VR and physiological tracking technologies.
  • Conditions:
  1. Identity Exchange with Exposure to Sexual Harassment (Experimental Condition 1)
  2. Identity Exchange without Harassment Exposure (Experimental Condition 2) 3. Third-person Observer Condition (Control Group)
  • Intervention Duration: One VR session (~60 minutes) with pre- and post-intervention assessments and a three-month follow-up.

Intervention Procedures

  1. Pre-intervention assessment
  • Participants complete self-report questionnaires measuring empathy, gender role attitudes, and harassment perceptions.
  • Baseline physiological measures (eye tracking and pupillometry) are recorded. - Participants are assigned to one of the three conditions.
  1. VR Intervention:
  • Participants undergo a mirror embodiment task to establish a sense of virtual body ownership.
  • The male participant embodies his female partner's avatar in a VR scenario (conditions 1 and 2).
  • Participants experience the designated VR scenario (harassment, neutral, or observational).
  • Physiological responses are collected in real time.
  1. Post-intervention assessment
  • Participants complete self-report measures to assess changes in empathy and gender attitudes.
  • Physiological data analysis (pupil dilation and eye gaze fixation) is conducted. - Semi-structured interviews explore subjective experiences.
  1. Three-month follow-up:
  • Participants complete longitudinal measures to assess sustained behavioral and attitudinal changes.

Outcome Measures

  1. Primary Outcome: Change in empathy scores (Interpersonal Reactivity Index). 2. Secondary Outcomes:
  • Gender role attitudes (Ambivalent Sexism Inventory).
  • Dyadic relationship quality and flourishing
  • Harassment-related attitudes - Eye-tracking and pupillometry responses during VR.
  • Qualitative insights from the post-intervention interviews.

Sample Size Justification A sample of 90 couples (180 individuals) was determined based on an estimated effect size of d = 0.5, an alpha risk of 0.05, and a power of 0.86. Participants will be randomized using block randomization (block sizes of 3 or 6) to ensure balance across the conditions.

Data Management and Quality Assurance

  1. Data Collection
  • Self-reported data will be collected using secure online survey tools.
  • Physiological data will be automatically recorded using VR-compatible eye-tracking and pupillometry systems.
  1. Data Validation and Security
  • The dataset will undergo automatic range checks to detect anomalies.
  • Double data entry procedures will be implemented for self-report responses.
  • Only authorized researchers will have access to identifiable data, stored on encrypted servers.
  1. Missing Data Handling:
  • Missing values will be addressed using multiple imputation techniques.
  • Sensitivity analyses will be conducted to determine the impact of the missing data.

Statistical Analysis Plan

  1. Primary Analysis:
  • Repeated measures ANOVA will assess within- and between-group differences in empathy scores over time.
  1. Secondary Analyses:
  • Generalized Estimating Equations (GEE) will model longitudinal changes in gender attitudes.
  • Mixed-effects models will analyze physiological responses (eye tracking and pupil dilation).
  • Qualitative data from the interviews will be subjected to thematic analysis using NVivo software.

Ethical Considerations

  • The study has received approval from the Research Ethics Committee of the Universitat Oberta de Catalunya.
  • Participants will provide informed consent prior to participation.
  • Psychological debriefing and support resources will be available to participants.

Dissemination Plan

The findings will be as follows:

  • Peer-reviewed journal publications.
  • Academic conferences in psychology, gender studies, and VR research.
  • Open science repositories for data transparency.
Being tested
REVISE - Virtual Reality Gender-Swap with Harassment Exposure, REVISE - Virtual Reality Gender-Swap without Harassment
Keywords
Sexual Harassment, Gender-Based Violence, Immersive Virtual Reality, Violence Prevention, Sexism, VR Intervention, Violence Against Woman
Medical subject headings
Sexual Harassment, Sexism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • REVISE - Virtual Reality Gender-Swap with Harassment ExposureBehavioural

    Participants will embody a virtual avatar of their female partner in a sexual harassment scenario using full-body tracking, and identity exchange in virtual reality (VR). The goal is to assess whether experiencing harassment from a first-person perspective increases empathy and decreases tolerance toward sexual harassment.

  • REVISE - Virtual Reality Gender-Swap without HarassmentBehavioural

    Participants will embody a virtual avatar of their female partner in a neutral social interaction scenario using VR-based identity exchange. This condition controls for the effect of perspective-taking alone, without exposure to harassment, to evaluate its impact on empathy and gender attitudes.

Study groups in NCT06839937
Study groupRoleWhat they receive
Identity Exchange with Exposure to Sexual HarassmentExperimentalParticipants will experience a virtual reality (VR) perspective-taking intervention in which they embody their female partner's avatar in a scenario depicting sexual harassment. This immersive experience aims to enhance empathy and reduce the acceptance of sexual harassment. Physiological responses (eye tracking and pupillometry) will be recorded, and participants will complete pre- and post-intervention self-reports.
Receives: Behavioral: REVISE - Virtual Reality Gender-Swap with Harassment Exposure
Identity Exchange without Harassment ExposureExperimentalParticipants will embody their female partner's avatar in a neutral VR scenario without any harassment. This condition serves to evaluate the effects of identity exchange alone, without exposure to gender-based violence, on empathy and gender attitudes. Pre- and post-intervention assessments and physiological measures will be collected.
Receives: Behavioral: REVISE - Virtual Reality Gender-Swap without Harassment
Third-Person Observer ConditionNo interventionParticipants will observe a VR scenario depicting sexual harassment from a third-person perspective, without experiencing identity exchange. This condition acts as a control to determine whether passive observation differs from immersive perspective-taking in modifying attitudes toward gender-based violence. Self-reports and physiological responses will be also analyzed.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Empathy Scores (Interpersonal Reactivity Index - IRI)

    Empathy will be assessed using the Interpersonal Reactivity Index (IRI), a validated self-report measure that evaluates different components of empathy, including perspective-taking and empathic concern. The IRI consists of 28 items, each rated on a 5-point Likert scale (0 = Does not describe me well to 4 = Describes me very well). The total score ranged from 0 to 112, with higher scores indicating greater levels of empathy. Cronbach's alpha ranged from .68 to .80. Participants will complete the IRI at baseline (pre-intervention), immediately post-intervention, and at a three-month follow-up to assess changes over time. Higher scores indicate greater empathy levels.

    Measured: Baseline, immediately post-intervention, 3-month follow-up

Secondary outcomes (10)

  1. Change in Gender Role Attitudes (Ambivalent Sexism Inventory - ASI)

    Gender role attitudes will be measured using the Ambivalent Sexism Inventory (ASI), which assesses two factors: hostile and benevolent sexism. We will use the brief version composed of 12 items (6 items in each factor) with Cronbach's alphas of .75 and .81. Higher scores indicate greater sexist attitudes. Participants will complete the ASI at baseline, post-intervention, and 3-month follow-up to evaluate changes in gender-related beliefs.

    Measured: Baseline, immediately post-intervention, 3-month follow-up

  2. Change in Communication Patterns (Communication Patterns Questionnaire - CPQ)

    Communication patterns in close relationships will be assessed using the Spanish version of the Communication Patterns Questionnaire (CPQ). The CPQ is a self-report measure that evaluates three dimensions of communication: mutual constructive communication, communication avoidance or demand/withdrawal, and aggressive communication. Participants will complete the CPQ at baseline (pre-intervention), immediately post-intervention, and at a three-month follow-up to assess changes in communication styles over time. The questionnaire consists of 24 items, each rated on a 9-point Likert scale ranging from 1 ("Very unlikely") to 9 ("Very likely"). Higher scores indicate greater use of the corresponding communication strategy. Cronbach alpha in Spain ranged from .62 to .84.

    Measured: Baseline, immediately post-intervention, 3-month follow-up

  3. Change in Relationship Satisfaction (Dyadic Adjustment Scale - DAS)

    We will use the Spanish brief version of the DAS. It is composed of 13 items answered in a variable Likert scale and those items are grouped under three second order factors and one of first order structure. The scale in its short form presents a cut-off of 44. The higher the score the best adjustment is observed. Cronbach alpha was .83.

    Measured: Baseline, immediately post-intervention, 3-month follow-up

  4. Change in Couple Flourishing (Couple Flourishing Measure - CFM)

    Couple flourishing will be assessed using the Couple Flourishing Measure (CFM), a unidimensional self-report instrument. The Spanish validated version by Saavedra-Roa et al. will be used in this study. Participants will complete the CFM at baseline (pre-intervention), immediately post-intervention, and at a three-month follow-up to assess changes in relationship satisfaction and flourishing over time. The questionnaire consists of 16 items, each rated on a 7-point visual analogue Likert scale ranging from 1 (Distressed relationship), 4 (Satisfied relationship), to 7 (Flourishing relationship). The total score ranges from 16 to 112, with higher scores indicating greater couple flourishing. The instrument demonstrated high internal consistency reliability (α = .94).

    Measured: Baseline, immediately post-intervention, 3-month follow-up

  5. Change in Acceptance of Modern Myths about Sexual Aggression (AMMSA Scale)

    Attitudes towards modern myths about sexual aggression will be assessed using the Acceptance of Modern Myths about Sexual Aggression Scale (AMMSA; Gerger et al., 2007). The Spanish adapted and validated version (Megías et al., 2011) will be used in this study. The AMMSA is a self-report measure designed to evaluate subtle beliefs that justify or minimize sexual aggression. Participants will complete the AMMSA at baseline (pre-intervention), immediately post-intervention, and at a three-month follow-up to assess changes in the acceptance of sexual aggression myths over time. The questionnaire consists of 30 items, each rated on a 7-point Likert scale, ranging from 1 ("Totally disagree") to 7 ("Totally agree"). Higher scores indicate greater acceptance of modern myths about sexual aggression. Cronbach alpha in a Spanish sample was .91.

    Measured: Baseline, immediately post-intervention, 3-month follow-up

  6. Change in Body Ownership Illusion

    Body ownership illusion will be assessed to measure the extent to which participants experience the illusion of embodying their self-avatar and their partner's avatar. This measure evaluates embodiment and agency from a first-person perspective during the VR experience. A validated four-item scale will be administered verbally in two phases: (1) mirror embodiment with the assistant and (2) farewell with the assistant . In the first phase, the assistant will instruct the participant to look into a virtual mirror and ask: "On a scale from 0 to 10, to what extent did you feel that the virtual body in the mirror was your own?" and "When looking down, did you feel that the virtual body was yours?" In the second phase, the assistant will ask: "Did you feel that you owned a different body?" and "Did you feel fear of aggression?" Higher scores indicate a stronger experience of embodiment.

    Measured: During VR exposure at two assessment points: (1) Mirror embodiment phase (approximately 5 minutes after VR start) and (2) Farewell phase (at the end of VR exposure, approximately 15 minutes after VR start).

  7. Change in Physiological Arousal (Pupillometry)

    Physiological arousal will be measured using pupillometry, which records minute fluctuations in the pupil diameter in response to stimuli. Pupil dilation is an indicator of autonomic nervous system activation, and greater pupil dilation is associated with negative emotional processing. The key metric recorded will be pupil diameter ratio (measured in millimeters): the relative change in pupil size in response to VR stimuli. The pupil data will be sampled at a minimum frequency of 60 Hz with a visual angle accuracy of 0.5°. Artifacts such as pupil amplitude outliers (<1 mm or >9 mm), drifts, and blinks will be coded as missing values. A 10 Hz low-pass filter will be applied to smooth the data.

    Measured: From the start of VR exposure until the completion of the VR session (approximately 15 minutes). Data will be collected in real-time during this period.

  8. Change in Visual Attention (Eye-Tracking Data)

    Visual attention will be assessed using eye tracking technology integrated into VR goggles. Eye tracking measures fixation behavior as an indicator of attention allocation toward erotic stimuli, based on sexual objectification theory (Hollett et al., 2022). Two key parameters will be recorded: 1) fixation count (measured in number of fixations): number of available fixations on a specified area of interest (VR model's neckline) and dwell time (measured in milliseconds), and total duration of fixations on the area of interest (neckline). Fixation was defined as a continuous gaze lasting at least 100 ms.

    Measured: From the start of VR exposure until the completion of the VR session (approximately 15 minutes). Data will be collected in real-time during this period.

  9. Changes in affective responses

    Self-Assessment Manikin (SAM) will be used to assess participants' affective responses during the intervention. This is a non-verbal, pictorial scale that evaluates three dimensions of emotional reaction: Valence (from negative/unpleasant to positive/pleasant), Arousal (from calm to excited), and Dominance (from feeling dominated to feeling in control). Each dimension is rated on a 9-point scale: 1 indicates the lowest intensity (e.g., unpleasant, calm, or dominated), and 9 indicates the highest intensity (e.g., pleasant, excited, or dominant). Higher scores represent more positive emotional valence, higher arousal, and greater sense of control or dominance

    Measured: During VR exposure at one assessment point: Farewell phase (at the end of VR exposure, approximately 15 minutes after VR start).

  10. Qualitative Insights from Participant Experience

    Participants will complete semi-structured interviews post-intervention to explore their experiences and perceptions of the VR embodiment task. Interviews will be transcribed and analyzed using thematic analysis to identify key themes related to empathy, gender role reflection, and perceived impact of the intervention.

    Measured: Immediately post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2025
  2. Study start30 Mar 2027 (estimated)
  3. Primary completion30 Mar 2027 (estimated)
  4. Study completion30 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to one of three independent intervention groups: 1. Identity Exchange with Exposure to Sexual Harassment: Male participants will embody their female partner's avatar in a VR harassment scenario. 2. Identity Exchange without Harassment Exposure: Male participants will embody their female partner's avatar in a neutral VR scenario. 3. Third-person Observer Condition: Male participants will observe a harassment scenario in VR without identity exchange. Each participant remains in their assigned condition throughout the study, and comparisons are made between groups based on empathy, gender attitudes, and harassment-related responses.
Masking
Single blind
Who is masked
Participant
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06839937
Sponsor's protocol ID
MCIN/AEI/10.13039/501100011033
Other IDs
PID2022-141198OB-I00
Acronym
REVISE
Status last verified
Mar 2026
First submitted
5 Feb 2025
Last updated
23 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared because of privacy and confidentiality concerns, as the study involves sensitive topics related to sexual harassment and gender identity. Given the nature of the intervention and the potential risk of re-identification, all collected data will be stored securely and will only be accessible to the research team in accordance with institutional ethical guidelines and data protection regulations (e.g., GDPR). Aggregated results will be published in peer-reviewed journals, but the raw participant-level data will remain confidential.

Publications

  • Carvalho J, Rosa PJ, Pereira B. Dynamic Risk Factors Characterizing Aggressive Sexual Initiation by Female College Students. J Interpers Violence. 2021 Mar;36(5-6):2455-2477. doi: 10.1177/0886260518760010. Epub 2018 Mar 5.

    PubMed 29502500

  • Hollett RC, Rogers SL, Florido P, Mosdell B. Body Gaze as a Marker of Sexual Objectification: A New Scale for Pervasive Gaze and Gaze Provocation Behaviors in Heterosexual Women and Men. Arch Sex Behav. 2022 Aug;51(6):2759-2780. doi: 10.1007/s10508-022-02290-y. Epub 2022 Mar 29.

    PubMed 35348918

  • Bradley MM, Lang PJ. Measuring emotion: the Self-Assessment Manikin and the Semantic Differential. J Behav Ther Exp Psychiatry. 1994 Mar;25(1):49-59. doi: 10.1016/0005-7916(94)90063-9.

    PubMed 7962581

  • Ventura S, Cardenas G, Miragall M, Riva G, Banos R. How Does It Feel to Be a Woman Victim of Sexual Harassment? The Effect of 360 degrees -Video-Based Virtual Reality on Empathy and Related Variables. Cyberpsychol Behav Soc Netw. 2021 Apr;24(4):258-266. doi: 10.1089/cyber.2020.0209. Epub 2020 Oct 20.

    PubMed 33085513

  • Jouriles EN, McDonald R, Kullowatz A, Rosenfield D, Gomez GS, Cuevas A. Can virtual reality increase the realism of role plays used to teach college women sexual coercion and rape-resistance skills? Behav Ther. 2009 Dec;40(4):337-45. doi: 10.1016/j.beth.2008.09.002. Epub 2008 Oct 31.

    PubMed 19892079

  • Riva G, Banos RM, Botella C, Mantovani F, Gaggioli A. Transforming Experience: The Potential of Augmented Reality and Virtual Reality for Enhancing Personal and Clinical Change. Front Psychiatry. 2016 Sep 30;7:164. doi: 10.3389/fpsyt.2016.00164. eCollection 2016.

    PubMed 27746747

  • Maister L, Slater M, Sanchez-Vives MV, Tsakiris M. Changing bodies changes minds: owning another body affects social cognition. Trends Cogn Sci. 2015 Jan;19(1):6-12. doi: 10.1016/j.tics.2014.11.001. Epub 2014 Dec 15.

    PubMed 25524273

  • Dobbin F, Kalev A. The promise and peril of sexual harassment programs. Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12255-12260. doi: 10.1073/pnas.1818477116. Epub 2019 Jun 3.

    PubMed 31160444

  • DeGue S, Valle LA, Holt MK, Massetti GM, Matjasko JL, Tharp AT. A systematic review of primary prevention strategies for sexual violence perpetration. Aggress Violent Behav. 2014 Jul-Aug;19(4):346-362. doi: 10.1016/j.avb.2014.05.004.

    PubMed 29606897

  • Gunarathne L, Bhowmik J, Apputhurai P, Nedeljkovic M. Factors and consequences associated with intimate partner violence against women in low- and middle-income countries: A systematic review. PLoS One. 2023 Nov 8;18(11):e0293295. doi: 10.1371/journal.pone.0293295. eCollection 2023.

    PubMed 37939106

  • Tourne Garcia M, Herrero Velazquez S, Garriga Puerto A. [Health consequences of violence against women by the couple]. Aten Primaria. 2024 Nov;56(11):102903. doi: 10.1016/j.aprim.2024.102903. Epub 2024 Mar 27. Spanish.

    PubMed 38538482

  • Saavedra-Roa A, Vallejo-Medina P, Seinfeld S, Bourdin-Kreitz P, Guillen-Riquelme A, Marsa-Sambola F, Medina JC, Pineda-Marin C, Paz C, Angulo-Brunet A, Montesano A. REVISE Virtual Reality Intervention to Prevent Sexual Harassment in Heterosexual Couples: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2026 May 14;15:e91993. doi: 10.2196/91993.

    PubMed 42133943

Questions about this trial

What is this clinical trial studying?

A study testing REVISE - Virtual Reality Gender-Swap with Harassment Exposure and REVISE - Virtual Reality Gender-Swap without Harassment in people with Sexual Harassment and Gender Based Violence, run by Universitat Oberta de Catalunya.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Adrián Montesano, Doctor (+34625624172, amontesano@uoc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Empathy Scores (Interpersonal Reactivity Index - IRI) (time frame: Baseline, immediately post-intervention, 3-month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06839937, which also lists 12 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in